Analgesic Effect of Sacral Submultifidus Block as an Adjunct to Sacroiliac Joint Injection
Analgesic Effect of Sacral Submultifidus Block as an Adjunct to Sacroiliac Joint Injection: A Randomized Controlled Double-Blind Trial
- Sacro Iliac Joint Pain
- Low Back Pain
- Sacroiliatis
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Fayoum University Hospital
- Enrolment target
- 54
- Started
- 1 September 2026
- Main results due
- 1 March 2027
- Study sites
- 1
- Registry updated
- 25 September 2026
Can you take part?
- Ages 21 years to 60 years.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1-patients aged above 21 years, both genders diagnosed with chronic sacroiliac joint pain with a rating on the numeric pain rating scale (NPRS) of at least 5, without radiculopathy lasting 3 months or longer, and Positive SI provocative tests: usually \> 3 positive tests ... 2-Failure of conservative therapy .3-Radiological exclusion of lumbar pathology. 4- Diagnostic SIJ block producing ≥75% pain relief. Exclusion Criteria: * 1\. refusal to participate. 2. Allergy or contraindication to local anesthetics. 3. Coagulation disorders or ongoing anticoagulant therapy. 4. Infection at the block injection site. 5. Chronic opioid use or substance abuse. 6. Neurological or psychiatric disorders affecting pain assessment. 7. Pregnancy.
What this study is about
In the sponsor’s own words, from the registry.
The aim of this study is to assess whether the addition of sacral submultifidus block to standard image-guided SIJ injection provides superior analgesia and functional improvement compared with SIJ injection alone in patients with chronic SIJ-mediated pain.
Study sites(1)
Fayoum university Hospitl
Al Fayyum, Egypt
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07814729. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me